ľֱ

Nephrology

General Nephrology

More in General Nephrology

Study: CKD Not Worsened With Gout Treatment

It might even help, researchers say

Nov 25, 2024
Photo of a person with gout receiving urate lowering therapy.
Potassium Binder Cuts Hyperkalemia Risk in HF Patients on Spironolactone

More patients taking sodium zirconium cyclosilicate achieved normokalemia vs placebo recipients

Nov 20, 2024
AHA over a photo of McCormick Place Convention Center in Chicago, IL.
Multimarker Urine Test Promises to Improve Lupus Nephritis Diagnosis, Prognosis

Accuracy above 85% in early testing -- far better than proteinuria and biopsy

Nov 18, 2024
ACR over a photo of Walter E. Washington Convention Center in Washington, D.C.
Multiple Chronic Conditions and Death; Diabetes Treatment for Gout

Also in TTHealthWatch: frailty as a predictor of dementia

Nov 16, 2024
TTUHSC EL PASO HEALTHWATCH with their logo and photos of Rick Lange, MD, and Elizabeth Tracey
FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes

Data too uncertain to support sotagliflozin in subset with chronic kidney disease, advisors say

Nov 01, 2024
FDA ADCOMM sotagliflozin over a computer rendering of chronic kidney disease.
Ex-Gov. May Face Charges Over COVID; Autism Dx Up 175%; Can Fasting Help Kidneys?

Health news and commentary gathered by ľֱ staff

Oct 31, 2024
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
FDA Staff Not Quite Sold on Sotagliflozin for T1D Patients With CKD

SGLT1/SGLT2 inhibitor has another shot in T1D, but now in more narrow patient population

Oct 30, 2024
 FDA ADCOMM sotagliflozin over a computer rendering of chronic kidney disease.
Colorado Teen Fights Kidney Failure After Eating McDonald's Quarter Pounders

Deadly E. coli outbreak has been tentatively traced to contaminated onions

Oct 30, 2024
A selfie of Brittany Randall and her daughter Kamberlyn Bowler in Grand Junction Colorado in the summer of 2024.
Wegovy Cut Albuminuria by Half in Non-Diabetic CKD

However, 24 weeks of the GLP-1 had no impact on eGFR

Oct 29, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
Early AKI Care Recommendations Did Not Improve Patient Outcomes

Personalized recs were made by team of physicians and pharmacists within an hour of diagnosis

Oct 29, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
SGLT2 Inhibitor Carry-Over Benefits Last How Long?

Trial follow-up defines the need for long-term treatment in protecting the kidneys and heart

Oct 29, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
Kidney Disease Genetic Risk Common in West Africans

Observational study points to genetic risk allele dose-response

Oct 29, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
No Kidney Benefit With Finerenone in Heart Failure Patients

Anti-mineralocorticoid agent reduced albuminuria, but not eGFR-based kidney outcome

Oct 28, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
Complement Inhibitor Shows Promise for Rare Kidney Disorder

Ravulizumab reduced proteinuria, stabilized eGFR in IgA nephropathy

Oct 28, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
More in General Nephrology